Vulnerability · CVE-2025-64778
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords.
Published Dec 2, 2025 · catalog updated Dec 2, 2025 · Mirion Medical EC2 Software NMIS BioDose
Last checked Oct 28, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2025-64778. EPSS is 0.12%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
Same product and reporting
- CVE-2025-62575 · High
- CVE-2025-61940 · High
- CVE-2025-64298 · High
- CVE-2025-64642 · High
- Severity
- High8.4
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.12%
- Remediation
- Version ranges on file
- Affected products
- vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.0
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor Mirion Medical EC2 Software NMIS BioDose 0 <23.00 <23.0
How to fix CVE-2025-64778
Upgrade
CVE-2025-64778 lists a fix boundary at 23.0. Compare the installed build with that boundary before you change production.
Version check
Seen in 0 <23.0
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2025-64778. EPSS is 0.12%. Act only if a listed version of Mirion Medical EC2 Software NMIS BioDose is installed.
Which versions are affected?
Compare what you have installed with Mirion Medical EC2 Software NMIS BioDose 0 <23.0 0 <23.0. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.12%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Dec 2, 2025 · EUVD
Detected
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
Dec 2, 2025 · EUVD
Updated
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
Sources
- CVE.orgVulnerability recordCVE-2025-64778
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2025-64778
30-day exploitation probability 0.12%
first.org - EUVDVulnerability recordEUVD-2025-200321
NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 28, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 28, 2026
- CVE.orgOct 28, 2026
- EUVDOct 27, 2026